<div><p>Equilibrium folding–unfolding transitions are hard to study in HIV-1 protease (PR) because of its autolytic properties. Further, the protease exhibits many tolerant point mutations some of which also impart drug resistance to the protein. It is conceivable that the mutations affect protein's function by altering its folding characteristics; these would clearly depend on the nature of the mutations themselves. In this background, we report here NMR studies on the effects of D25 N mutation, which removes one negative charge from the protein at the active site, on the equilibrium folding behaviour of PR starting from its acetic acid denatured state. It is observed that in PR<sub>D25N</sub> two slowly exchanging conformations are presen...
AbstractUnderstanding protein folding requires complete characterization of all the states of the pr...
Under the selective pressure of therapy, HIV-1 protease mutants resistant to inhibitors evolve to co...
AbstractConformational sampling of pre- and post-therapy subtype B HIV-1 protease sequences derived ...
Folding, in-vivo, starts from a denatured state and thus the nature of the denatured state would pla...
BACKGROUND: The human immunodeficiency virus type 1 (HIV-1) protease is an essential viral protein t...
Enzyme targets in rapidly replicating systems, such as retroviruses, commonly respond to drug-select...
Folding studies on proteases by the conventional hydrogen exchange experiments are severely hampered...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of a...
Under the selective pressure of therapy, HIV-1 protease mutants resistant to inhibitors evolve to co...
Drug resistance to HIV-1 protease involves the accumulation of multiple mutations in the protein...
AbstractUnderstanding protein folding requires complete characterization of all the states of the pr...
Under the selective pressure of therapy, HIV-1 protease mutants resistant to inhibitors evolve to co...
AbstractConformational sampling of pre- and post-therapy subtype B HIV-1 protease sequences derived ...
Folding, in-vivo, starts from a denatured state and thus the nature of the denatured state would pla...
BACKGROUND: The human immunodeficiency virus type 1 (HIV-1) protease is an essential viral protein t...
Enzyme targets in rapidly replicating systems, such as retroviruses, commonly respond to drug-select...
Folding studies on proteases by the conventional hydrogen exchange experiments are severely hampered...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
The evolution of structural proteins is generally constrained by the folding stability. However, lit...
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of a...
Under the selective pressure of therapy, HIV-1 protease mutants resistant to inhibitors evolve to co...
Drug resistance to HIV-1 protease involves the accumulation of multiple mutations in the protein...
AbstractUnderstanding protein folding requires complete characterization of all the states of the pr...
Under the selective pressure of therapy, HIV-1 protease mutants resistant to inhibitors evolve to co...
AbstractConformational sampling of pre- and post-therapy subtype B HIV-1 protease sequences derived ...